The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The MATRiX trial: A multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1–refractory Merkel cell carcinoma.
 
Rashmi Bhakuni
Patents, Royalties, Other Intellectual Property - Co-author; "SUBSTITUTED 1,2- DIHYDRO-3H-PYRAZOLO[4,3-C]QUINOLIN-3-ONE AS ATR KINASE INHIBITORS", granted by the Government of India on June 19th, 2023. (Inst)
 
Evan Hall
Consulting or Advisory Role - Eisai
Research Funding - Gilead Sciences (Inst); ImCheck therapeutics (Inst); Nektar (Inst); Neoleukin Therapeutics (Inst); NiKang Therapeutics (Inst); Pfizer (Inst); Replimune (Inst)
 
George Ansstas
Consulting or Advisory Role - Novartis
Research Funding - Novocure
 
Shailender Bhatia
Honoraria - Bristol-Myers Squibb; Incyte; Replimune
Consulting or Advisory Role - Bristol Myers Squibb; Incyte; Replimune
Research Funding - Agenus (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); Incyte (Inst); Merck (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Andrew Brohl
Consulting or Advisory Role - Deciphera
Research Funding - Merck (Inst)
 
Melissa Burgess
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie
Research Funding - Merck
 
Maya Dimitrova
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer
 
Ling Gao
No Relationships to Disclose
 
Jeffrey Ishizuka
Stock and Other Ownership Interests - Curios Therapeutics; Jounce Therapeutics; Kronos Bio
Consulting or Advisory Role - Danger Bio; Fortress Biotech; Ono Pharmaceutical; Phenomic AI; Rheos Medicines; Tango Therapeutics; Two River Group
Research Funding - AstraZeneca/MedImmune
Patents, Royalties, Other Intellectual Property - I am an inventor on a patent on approaches targeting dsRNA sensing titled: "MODULATING dsRNA EDITING, SENSING, AND METABOLISM TO INCREASE TUMOR IMMUNITY AND IMPROVE THE EFFICACY OF CANCER IMMUNOTHERAPY AND/OR MODULATORS OF INTRATUMORAL INTERFERON".
 
Evan Lipson
Stock and Other Ownership Interests - Iovance Biotherapeutics
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; CareDX; HUYA Bioscience International; Immunocore; Instil Bio; IO Biotech; Merck; Merck KGaA; Nektar; Novartis; OncoSec; Pfizer; Rain Therapeutics; Regeneron; Replimune; Sun Pharma; Syneos Health
Research Funding - 1104Health (Inst); Bristol-Myers Squibb (Inst); Haystack Oncology (Inst); Merck (Inst); Regeneron (Inst); Sanofi (Inst)
 
Jose Lutzky
Consulting or Advisory Role - Castle Biosciences
Research Funding - AsherBio (Inst); Bristol-Myers Squibb (Inst); Dragonfly Therapeutics (Inst); Erasca, Inc (Inst); Immatics (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Regeneron (Inst); Replimune (Inst); Syntrix Biosystems (Inst); TriSalus Life Sciences (Inst); Vyriad (Inst)
Travel, Accommodations, Expenses - Castle Biosciences; Erasca, Inc
 
Ann Silk
Stock and Other Ownership Interests - gral; Illumina
Consulting or Advisory Role - Merck; Regeneron
Research Funding - Checkmate Pharmaceuticals (Inst); Merck (Inst); Morphogenesis (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Jina Yun
No Relationships to Disclose
 
Isaac Brownell
No Relationships to Disclose
 
Judy Murray
No Relationships to Disclose
 
Yvonne Mowery
Employment - Duke Health Private Diagnostic Clinic; UPMC Hillman Cancer Center/University of Pittsburgh
Honoraria - Oakstone; UpToDate
Consulting or Advisory Role - Catalys Pacific
Research Funding - Merck (Inst)
 
Ted Gooley
Consulting or Advisory Role - REGiMMUNE
 
Steven Gore
No Relationships to Disclose
 
Suzanne Topalian
Stock and Other Ownership Interests - Arcturus Therapeutics; Atengen; Clasp Therapeutics (I); Dracen (I); Dragonfly Therapeutics; Enara Bio (I); RAPT Therapeutics (I); Tizona Therapeutics, Inc. (I); TRex Bio (I)
Consulting or Advisory Role - Amgen (I); Arcturus Therapeutics; Bristol-Myers Squibb/Celgene; Compugen (I); Dracen (I); Dragonfly Therapeutics; Immunocore; Immunocore; Immunomic Therapeutics (I); Janssen (I); Normunity (I); PATHAI; RAPT Therapeutics (I); Regeneron; Takeda (I); Tizona Therapeutics, Inc. (I)
Research Funding - Bristol-Myers Squibb; Compugen (I); Enara Bio (I); Immunomic Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb (I); Immunonomic Therapeutics (I); Intellectual property related to MSI as an immunotherapy biomarker. (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dragonfly Therapeutics
 
Paul Nghiem
Leadership - Society for Investigative Dermatology (SID)
Honoraria - UpToDate
Consulting or Advisory Role - Almirall
Research Funding - Incyte (Inst)
Patents, Royalties, Other Intellectual Property - Patent filed: "Merkel cell polyomavirus T antigen-specific TCRs and uses thereof" (Inst); Patent pending for high affinity T cell receptors that target the Merkel polyomavirus.